Urologix, Inc. Urologix, Inc.

Urologix, Inc.

ULGX

Rank in Stocks #34797
Established in 1991 and headquartered in Minneapolis, Minnesota, Urologix, Inc.... Established in 1991 and headquartered in Minneapolis, Minnesota, Urologix, Inc. specializes in the development, production, promotion, and distribution of minimally invasive medical devices across the United States. The company's innovative solutions target the treatment of obstructions and related symptoms caused by benign prostatic hyperplasia (BPH). Among its key offerings is Cooled ThermoTherapy, a system that precisely applies microwave energy while simultaneously employing a cooling mechanism to safeguard healthy tissues and improve patient comfort. Urologix also provides the Prostiva RF Therapy System, which directs radio frequency energy into the prostate gland. This process works to eliminate problematic prostatic tissue, consequently easing urethral constriction and alleviating BPH-related discomfort. Urologix, Inc. caters to both healthcare professionals and patients.
Share Price
$0.0001
Last synced: 2026-11-13
Market Cap
$2.18K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Urologix, Inc. (ULGX)
Operating Margin as of November 2026 TTM: -48.68%
According to Urologix, Inc.'s latest financial reports, its current operating margin (TTM) is -48.68%. At the end of 2014 the company had an operating margin of -48.68%.
Operating Margin history for Urologix, Inc. from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -48.68% 0.00%
2014 -48.68% 105.92%
2013 -23.64% -2.88%
2012 -24.34% -17.88%
2011 -29.64% 93.98%
2010 -15.28% -56.14%
2009 -34.84% -69.08%
2008 -112.69% 168.95%
2007 -41.90% -1,510.77%
2006 2.97% -75.45%
2005 12.10% 402.07%
2004 2.41% -104.45%
2003 -54.17% 553.44%
2002 -8.29% -78.38%
2001 -38.35% -63.49%
2000 -105.04% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
15.00% -100.31%
US
18.08% -100.37%
IE
21.25% -100.44%
US
21.05% -100.43%
US
25.52% -100.52%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Urologix, Inc.'s operating margin

What is Urologix, Inc.'s operating margin?

Urologix, Inc.'s operating margin is -48.68%, as of Nov 2026.

What was Urologix, Inc.'s operating margin in 2014?

In 2014, Urologix, Inc.'s operating margin was -48.68%, compared with -23.64% in 2013.

How has Urologix, Inc.'s operating margin changed since 2009?

From 2009 to 2014, Urologix, Inc.'s operating margin was highest in 2010 (-15.28%) and lowest in 2014 (-48.68%).

How does Urologix, Inc.'s operating margin compare with similar companies?

Urologix, Inc.'s operating margin (-48.68%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 25.52%.